Delivery Order SPE2DB20D3505-SPE2DB25FT3P2

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,760.02 firm fixed price contract provides 4,562,878,752 units of Fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of November 22, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The order is for 4,560,588 units of Fexofenadine HCL 180 mg tablets, at a fixed price of $1,574.05. The order is placed under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,407.38, is for the delivery of fexofenadine hydrochloride 180 mg tablets. The contract has a performance period through March 13, 2025 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a $1,931.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the supply of Fexofenadine HCL 180 mg tablets, a prescription medication, with a period of performance through July 2, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,559.97 Firm Fixed Price delivery order contract is for the supply of 4,565,122,465 units of Fexofenadine HCL 180 mg tablets. The contract has a period of performance through July 12, 2024 and was awarded on July 11, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,159.51, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fexofenadine HCL 180 mg tablets. The $1,813.85 firm-fixed-price contract has a completion date of September 26, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and $750,000, respectively, to provide a wide range of pharmaceutical and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,064.90, is for the delivery of Fexofenadine HCl 180 mg tablets. The contract is not designated as a set-aside. It is a firm fixed-price delivery order that supports the DLA Troop Support Medical program, which provides medical products and supplies to military treatment facilities,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $3,345.46 and covers the delivery of 4,563,927,453 units of Fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of March 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,223.49 firm fixed-price delivery order is for the supply of Fexofenadine Hydrochloride 180 mg Tablets, a prescription medication. The award has an ultimate completion date of August 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB25FT3P2
    Delivery Order

This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,083.61, is for the delivery of Fexofenadine HCL 180 mg tablets.

The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and there is no information provided about any subcontractors. The contract is for Firm Fixed Price delivery of the specified pharmaceutical product to the place of performance in Conshohocken, Pennsylvania.

Generated 5/20/25, 2:10 PM